2023 Year in Review: Our Focus on Cancer

Поділитися
Вставка
  • Опубліковано 8 лют 2025
  • Our broad and deep pipeline of combinatorial agents continues to unlock new opportunities to leverage the immune system to address a broad spectrum of cancers and blood disorders.

КОМЕНТАРІ •